IL-18 代谢重编程表达 CAR 的自然杀伤 T 细胞并增强其抗肿瘤活性
IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity.
76.4分
★★★★☆
站内排序·非疗效
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
前沿论文 4
血液系统恶性肿瘤的双靶向 CAR-T 细胞免疫治疗：2023 ASH 年会最新进展
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting.
63.6分
★★★☆☆
站内排序·非疗效
iNKT 激动剂 ABX196 作为一种新型癌症免疫治疗增强剂在黑色素瘤和肝癌小鼠模型中的抗肿瘤活性展示
Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Mo
46.9分
★★★☆☆
站内排序·非疗效
CD19-嵌合抗原受体-恒定自然杀伤 T 细胞反式激活 NK 细胞并降低同种反应性
CD19-chimeric antigen receptor-invariant natural killer T cells transactivate NK cells and reduce alloreactivity.
33.1分
★☆☆☆☆
站内排序·非疗效
共 4 条